1. Start as close to the source as possible
Regulatory stories begin with regulators and legal text. Research stories begin with the paper, registry, or indexed abstract. Cultural history begins with scholarship, museums, archives, or accountable community sources. Press coverage may help us find a story but does not replace the record.
2. Separate the layers
Every file distinguishes what happened, what the evidence measured, what remains uncertain, and our practical interpretation. Proposed rules remain proposals. Association remains association. A product-specific trial does not become an ingredient-wide verdict.
3. Grade the claim
The letter is a reading aid, not a verdict on a brand, country, culture, ingredient, or treatment. An official recall can be an A for the fact that the recall happened while saying nothing about unrelated products.
4. Check the pressure points
- Population, sample size, comparator, duration, and outcome relevance.
- Funding, product provision, author conflicts, and branded multi-product protocols.
- Whether the finding travels across skin tones, climates, markets, doses, and finished formulas.
- Whether a safety or regulatory action applies to one item, one company, or an entire category.
5. Date the review and preserve the link
Every developing story carries a date. When the underlying status changes, the file gains a dated update or correction rather than a silent rewrite, and the change is listed on the corrections page.
Medical boundary
Skin Considered provides journalism and education, not diagnosis or individualized treatment. Urgent symptoms, changing lesions, infection, severe reactions, scarring disease, and procedure complications need qualified care.